Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE000A2P4LJ5
Tue, 05.11.2024
PharmaSGP Holding SE
PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer
Gräfelfing, November 05, 2024 – Peter Gerckens, who has been a member of the Management Board of PharmaSGP Holding SE as Chief Commercial Officer (CCO) since July 1, 2024, will take over the position of Chief Executive Officer (CEO) of the company on January [ … ]
Thu, 12.09.2024
PharmaSGP Holding SE
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE AD-HOC RELEASE.
Disclosure of an inside information acc. to Art. 17 [ … ]
Thu, 18.04.2024
PharmaSGP Holding SE
Publication of inside information in accordance with Article 17 of Regulation (EU) No 596/2014
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
Gräfelfing, April 18, 2024 – The Management Board and Supervisory Board of PharmaSGP Holding SE (ISIN DE000A2P4LJ5) will propose to this year's Annual General Meeting [ … ]